Hypertension Trial, Recruiting NCT06935513 Sponsor: Affiliated Hospital of Nantong University Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06935513
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with high blood pressure (hypertension)
  • You have been diagnosed with diabetes
  • You have been diagnosed with atrial fibrillation (an irregular heartbeat condition)
  • You are a smoker
  • You are not physically active on a regular basis
  • You are considered overweight or obese
  • You are able to use smart wearable devices (such as a smartwatch or fitness tracker)

Who may not be able to join:

  • You have been diagnosed with cancer (malignancies)
  • You have been diagnosed with a psychiatric (mental health) disorder
  • You have been diagnosed with cognitive impairment (such as problems with memory or thinking)
  • You are unable to operate or use smart wearable devices

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Affiliated Hospital of Nantong University
Registry
ClinicalTrials.gov
Start date
20 April 2025
Est. completion
20 October 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

medication adherence and risk factor control rates

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov